Introduction to the special supplement, unlocking the potential of self-injectable contraception: evidence from coordinated investments

Affiliations

¹ Department of Social and Behavioral Sciences, Institute for Health and Aging, University of California, San Francisco, San Francisco, CA, United States of America. Erica.Sedlander@ucsf.edu.
² Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
³ Department of Social and Behavioral Sciences, Institute for Health and Aging, University of California, San Francisco, San Francisco, CA, United States of America.
⁴ PATH, Seattle, WA, United States of America.

Editorial

Erica Sedlander et al. BMC Womens Health. 2025.

. 2025 Sep 19;25(Suppl 1):430.

doi: 10.1186/s12905-025-04025-2.

¹ Department of Social and Behavioral Sciences, Institute for Health and Aging, University of California, San Francisco, San Francisco, CA, United States of America. Erica.Sedlander@ucsf.edu.
² Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
³ Department of Social and Behavioral Sciences, Institute for Health and Aging, University of California, San Francisco, San Francisco, CA, United States of America.
⁴ PATH, Seattle, WA, United States of America.

No abstract available

Conflict of interest statement

Declarations. Competing interests: The authors have no competing interests to disclose.

1. World Health Organization. WHO recommendations on self-care interventions: self-administration of injectable contraception [Internet]. Geneva: World Health Organization. 2020 p. 4. Available from: https://apps.who.int/iris/handle/10665/332332.
1. Askew I, Wells E. DMPA-SC: an emerging option to increase women’s contraceptive choices. Contraception [Internet]. 2018; Available from: http://www.sciencedirect.com/science/article/pii/S0010782418304025. - PubMed
1. Emily Himes L, Suchman M, Kamanga C, Birabwa S, Gitome E, Omoluabi, et al. Women’s perspectives on the unique benefits and challenges of self-injectable contraception: A four-country in-depth interview study in sub-Saharan Africa. Stud Fam Plann. 2024;55(4):269–90. 10.1111/sifp.12277. https://onlinelibrary.wiley.com/doi/. - PMC - PubMed
1. Burke HM, Packer C, Wando L, Wandiembe SP, Muwereza N, Pradhan S, et al. Adolescent and covert family planning users’ experiences self-injecting contraception in Uganda and Malawi: implications for waste disposal of subcutaneous depot medroxyprogesterone acetate. Reprod Health. 2020;17(1):117. - PMC - PubMed
1. Cover J, Ba M, Lim J, Drake JK, Daff BM. Evaluating the feasibility and acceptability of self-injection of subcutaneous depot Medroxyprogesterone acetate (DMPA) in senegal: a prospective cohort study. Contraception. 2017;96(3):203–10. - PMC - PubMed